Literature DB >> 3300527

Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection.

J L Ho, M Barza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3300527      PMCID： PMC174764          DOI： 10.1128/AAC.31.4.485

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  42 in total

1.  Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections.

Authors:  F P Tally; J M Kellum; J L Ho; T F O'Donnell; M Barza; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

2.  Comparison of cefuroxime and gentamicin in combination with metronidazole in the treatment of peritonitis due to perforation of the appendix.

Authors:  I Saario; H Arvilommi; H Silvola
Journal:  Acta Chir Scand       Date:  1983

3.  Sample size nomograms for interpreting negative clinical studies.

Authors:  M J Young; E A Bresnitz; B L Strom
Journal:  Ann Intern Med       Date:  1983-08       Impact factor: 25.391

4.  A comparison of metronidazole and clindamycin for the treatment of intra-abdominal anaerobic infection: a multicentre trial.

Authors:  P Van der Auwera; J Collier; R J Goris; I Saario; A T Willis
Journal:  J Antimicrob Chemother       Date:  1982-07       Impact factor: 5.790

5.  A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections.

Authors:  G L Drusano; J W Warren; A J Saah; E S Caplan; J H Tenney; S Hansen; J Granados; H C Standiford; E H Miller
Journal:  Surg Gynecol Obstet       Date:  1982-05

6.  Rational use of antibiotics for perforated appendicitis in childhood.

Authors:  I B David; J R Buck; R M Filler
Journal:  J Pediatr Surg       Date:  1982-10       Impact factor: 2.545

7.  Perforated and gangrenous appendicitis: an analysis of antibiotic failures.

Authors:  P N Heseltine; A E Yellin; M D Appleman; M A Gill; F C Chenella; J W Kern; T V Berne
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

8.  A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis.

Authors:  J J Schentag; P B Wels; D P Reitberg; P Walczak; J H Van Tyle; R J Lascola
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

9.  A model system to demonstrate that beta-lactamase-associated antibiotic trapping could be a potential means of resistance.

Authors:  L Gutmann; R Williamson
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

10.  Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis.

Authors:  F J McLaughlin; W J Matthews; D J Strieder; B Sullivan; D A Goldmann
Journal:  J Antimicrob Chemother       Date:  1983-05       Impact factor: 5.790
View more
  12 in total

1.  Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections.

Authors:  J S Solomkin; E P Dellinger; N V Christou; R W Busuttil
Journal:  Ann Surg       Date:  1990-11       Impact factor: 12.969

2.  Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.

Authors:  M E Falagas; L Barefoot; J Griffith; R Ruthazar; D R Snydman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

Review 3.  Piperacillin/tazobactam in the treatment of polymicrobial infections.

Authors:  S L Gorbach
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

4.  Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.

Authors:  D J Walters; J S Solomkin; J A Paladino
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

5.  Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group.

Authors:  H Dupont; C Carbon; J Carlet
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

6.  Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections.

Authors:  Philippe Montravers; Annie Chalfine; Remy Gauzit; Alain Lepape; Jean Pierre Marmuse; Corinne Vouillot; Claude Martin
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

7.  Effect of peritoneal fluid pH on outcome of aminoglycoside treatment of intraabdominal infections.

Authors:  H P Simmen; H Battaglia; T Kossmann; J Blaser
Journal:  World J Surg       Date:  1993 May-Jun       Impact factor: 3.352

8.  Renoprotective effect of erdosteine in rats against gentamicin nephrotoxicity: a comparison of 99mTc-DMSA uptake with biochemical studies.

Authors:  Mehmet Cabuk; Ahmet Gurel; Feyza Sen; Nejat Demircan
Journal:  Mol Cell Biochem       Date:  2007-09-25       Impact factor: 3.396

9.  Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections.

Authors:  A P Walker; R L Nichols; R F Wilson; B A Bivens; D D Trunkey; C E Edmiston; J W Smith; R E Condon
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

10.  Spirulina platensis protects against renal injury in rats with gentamicin-induced acute tubular necrosis.

Authors:  Nesina Avdagić; Esad Cosović; Emina Nakas-Ićindić; Zakira Mornjaković; Asija Zaciragić; Almira Hadzović-Dzuvo
Journal:  Bosn J Basic Med Sci       Date:  2008-11       Impact factor: 3.363
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.